Literature DB >> 19132764

Sensory testing of the human gastrointestinal tract.

Christina Brock1, Lars Arendt-Nielsen, Oliver Wilder-Smith, Asbjørn Mohr Drewes.   

Abstract

The objective of this appraisal is to shed light on the various approaches to screen sensory information in the human gut. Understanding and characterization of sensory symptoms in gastrointestinal disorders is poor. Experimental methods allowing the investigator to control stimulus intensity and modality, as well as using validated methods for assessing sensory response have contributed to the understanding of pain mechanisms. Mechanical stimulation based on impedance planimetry allows direct recordings of luminal cross-sectional areas, and combined with ultrasound and magnetic resonance imaging, the contribution of different gut layers can be estimated. Electrical stimulation depolarizes free nerve endings non-selectively. Consequently, the stimulation paradigm (single, train, tetanic) influences the involved sensory nerves. Visual controlled electrical stimulation combines the probes with an endoscopic approach, which allows the investigator to inspect and obtain small biopsies from the stimulation site. Thermal stimulation (cold or warm) activates selectively mucosal receptors, and chemical substances such as acid and capsaicin (either alone or in combination) are used to evoke pain and sensitization. The possibility of multimodal (e.g. mechanical, electrical, thermal and chemical) stimulation in different gut segments has developed visceral pain research. The major advantage is involvement of distinctive receptors, various sensory nerves and different pain pathways mimicking clinical pain that favors investigation of central pain mechanisms involved in allodynia, hyperalgesia and referred pain. As impairment of descending control mechanisms partly underlies the pathogenesis in chronic pain, a cold pressor test that indirectly stimulates such control mechanisms can be added. Hence, the methods undoubtedly represent a major step forward in the future characterization and treatment of patients with various diseases of the gut, which provides knowledge to clinicians about the underlying symptoms and treatment of these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19132764      PMCID: PMC2653306          DOI: 10.3748/wjg.15.151

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  83 in total

Review 1.  Gastrointestinal tone.

Authors:  H Gregersen; J Christensen
Journal:  Neurogastroenterol Motil       Date:  2000-12       Impact factor: 3.598

2.  Three-dimensional biomechanical properties of the human rectum evaluated with magnetic resonance imaging.

Authors:  J B Frøkjaer; D Liao; A Bergmann; B P McMahon; E Steffensen; A M Drewes; H Gregersen
Journal:  Neurogastroenterol Motil       Date:  2005-08       Impact factor: 3.598

3.  Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and rectum.

Authors:  Willem Brinkert; Georg Dimcevski; Lars Arendt-Nielsen; Asbjørn M Drewes; Oliver H G Wilder-Smith
Journal:  Pain       Date:  2007-01-25       Impact factor: 6.961

4.  Multimodal pain stimulations in patients with grade B oesophagitis.

Authors:  A M Drewes; H Reddy; J Pedersen; P Funch-Jensen; H Gregersen; L Arendt-Nielsen
Journal:  Gut       Date:  2005-08-09       Impact factor: 23.059

5.  A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.

Authors:  Camilla Staahl; Lona Louring Christrup; Søren Due Andersen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Pain       Date:  2006-04-04       Impact factor: 6.961

Review 6.  Experimental human pain models in gastro-esophageal reflux disease and unexplained chest pain.

Authors:  Asbjørn Mohr Drewes; Lars Arendt-Nielsen; Peter Funch-Jensen; Hans Gregersen
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

7.  Identification of the biomechanical factors associated with the perception of distension in the human esophagus.

Authors:  J D Barlow; H Gregersen; D G Thompson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-04       Impact factor: 4.052

8.  Mechanical properties in the human gastric antrum using B-mode ultrasonography and antral distension.

Authors:  H Gregersen; O H Gilja; T Hausken; A Heimdal; C Gao; K Matre; S Ødegaard; A Berstad
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

9.  Gut pain and hyperalgesia induced by capsaicin: a human experimental model.

Authors:  Asbjørn Mohr Drewes; Klaus Peter Schipper; Georg Dimcevski; Poul Petersen; Hans Gregersen; Peter Funch-Jensen; Lars Arendt-Nielsen
Journal:  Pain       Date:  2003-07       Impact factor: 6.961

10.  Development of esophageal hypersensitivity following experimental duodenal acidification.

Authors:  Anthony R Hobson; Radia W Khan; Sanchoy Sarkar; Paul L Furlong; Qasim Aziz
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

View more
  5 in total

1.  New technologies in gastrointestinal research.

Authors:  Asbjørn Mohr Drewes; Hans Gregersen
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

2.  [Illustrations of visceral referred pain. "Head-less" Head's zones].

Authors:  C Henke; F Beissner
Journal:  Schmerz       Date:  2011-04       Impact factor: 1.107

Review 3.  Unravelling the mystery of capsaicin: a tool to understand and treat pain.

Authors:  Jessica O'Neill; Christina Brock; Anne Estrup Olesen; Trine Andresen; Matias Nilsson; Anthony H Dickenson
Journal:  Pharmacol Rev       Date:  2012-10       Impact factor: 25.468

4.  Sensitivity of quantitative sensory models to morphine analgesia in humans.

Authors:  Anne Estrup Olesen; Christina Brock; Eva Sverrisdóttir; Isabelle Myriam Larsen; Asbjørn Mohr Drewes
Journal:  J Pain Res       Date:  2014-12-09       Impact factor: 3.133

5.  Rectal hyposensitivity.

Authors:  Rebecca E Burgell; S Mark Scott
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.